Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sucrolo
- Development stage
- Unknown
- Lead developer
- Peak Health Foundation
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sucrolo is a dietary supplement developed by the Peak Health Foundation, marketed for the maintenance of healthy blood sugar levels and metabolic support. It is part of a suite of Ayurvedic-inspired wellness products that utilize botanical extracts, such as Kriya hops, to influence metabolic pathways. Positioned as a "sugar blocker," the product is intended for consumer use to assist in glucose management. As a nutraceutical, it has not undergone the standard FDA pharmaceutical approval process, and detailed clinical trial data or specific molecular mechanisms of action are not publicly documented in traditional drug pipelines.
- Brand names
- Sucrolo
Beyond the preview
Go deeper on Sucrolo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sucrolo.